Does intermittently scanned continuous glucose monitoring improve HbA1c and reduce hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies compared to blood glucose monitoring?
Intermittently scanned continuous glucose monitoring is associated with improved glycemic control and reduced diabetes-related hospitalizations in adults with type 2 diabetes on insulin.
This study shows that Swedish adults with type 2 diabetes on insulin who are using isCGM have a significantly reduced HbA1c and fewer hospital admissions for diabetes-related complications compared with BGM control participants.
Nathanson et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: